WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that the company will participate at the 44th Annual Meeting of the Drug Information Association (DIA), to be held June 22-26 at the Boston Convention and Exhibition Center. Company executives will help drive nine key sessions, discussing a range of topics including the role of electronic health records (EHRs) in clinical research, the criticality of CDISC and HL7 standards, the use of EDC to detect fraud in electronic records, as well as the evolving relationship building between CROs and EDC companies and what is needed to build a trusted, scalable IT infrastructure for global trials. Full session details are as follows:
